299 related articles for article (PubMed ID: 33550915)
41. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
[TBL] [Abstract][Full Text] [Related]
42. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
[TBL] [Abstract][Full Text] [Related]
43. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
44. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
[TBL] [Abstract][Full Text] [Related]
45. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
46. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
[TBL] [Abstract][Full Text] [Related]
47. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Xu Z; Jiang P; He S
Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
[TBL] [Abstract][Full Text] [Related]
48. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
[TBL] [Abstract][Full Text] [Related]
49. Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis.
Xu JS; Liao KL; Wang X; He J; Wang XZ
J Cell Mol Med; 2020 Dec; 24(24):14128-14138. PubMed ID: 33164330
[TBL] [Abstract][Full Text] [Related]
50. The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis.
Nie Y; Huang F; Lou L; Yan J
Med Sci Monit; 2022 Feb; 28():e934424. PubMed ID: 35184130
[TBL] [Abstract][Full Text] [Related]
51. Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma.
Zhao X; Weng W; Jin M; Li S; Chen Q; Li B; Zhou Z; Lan C; Yang Y
Med Sci Monit; 2021 Mar; 27():e929023. PubMed ID: 33658475
[TBL] [Abstract][Full Text] [Related]
52. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
53. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
54. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
Li Z; Xu J; Cui H; Song J; Chen J; Wei J
Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
[TBL] [Abstract][Full Text] [Related]
55. Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis.
Zeng X; Shi G; He Q; Zhu P
Sci Rep; 2021 Oct; 11(1):20799. PubMed ID: 34675265
[TBL] [Abstract][Full Text] [Related]
56. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system.
Xiao B; Hang J; Lei T; He Y; Kuang Z; Wang L; Chen L; He J; Zhang W; Liao Y; Sun Z; Li L
Mol Biol Rep; 2019 Apr; 46(2):2111-2119. PubMed ID: 30888555
[TBL] [Abstract][Full Text] [Related]
57. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
58. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
59. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
[TBL] [Abstract][Full Text] [Related]
60. Collagen family genes and related genes might be associated with prognosis of patients with gastric cancer: an integrated bioinformatics analysis and experimental validation.
Weng K; Huang Y; Deng H; Wang R; Luo S; Wu H; Chen J; Long M; Hao W
Transl Cancer Res; 2020 Oct; 9(10):6246-6262. PubMed ID: 35117235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]